Greater Cannabis Company (GCAN) Shares Outstanding (Weighted Average) (2016 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Shares Outstanding (Weighted Average) of $944935.0 in Q1 2026, up 14.54% quarter-over-quarter from $824984.0 in Q4 2025, and down 99.9% on a YoY basis from $910.4 million in Q1 2025.
Greater Cannabis Company (GCAN) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $944935.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 99.9% year-over-year to $944935.0; the TTM figure through Mar 2026 stood at $944935.0 (down 99.9% YoY), while the FY2025 annual figure was $824984.0, up 53.74% from the prior year.
- Shares Outstanding (Weighted Average) was $944935.0 for Q1 2026 at Greater Cannabis Company, up from $824984.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q2 2025 to a low of $536622.0 in Q3 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $525.3 million across 5 years, with a median of $617.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 99.93% in 2024, then surged 59.92% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $587.8 million in 2022, then increased by 28.48% to $755.2 million in 2023, then plunged by 99.93% to $536622.0 in 2024, then jumped by 53.74% to $824984.0 in 2025, then rose by 14.54% to $944935.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $944935.0 (Q1 2026), $824984.0 (Q4 2025), and $788524.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Greater Cannabis Company | - | - | - | 944,935.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,935.00 |
| Dec 31, 2025 | 824,984.00 |
| Sep 30, 2025 | 788,524.00 |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 910.37 Mn |
| Dec 31, 2024 | 536,622.00 |
| Sep 30, 2024 | 536,622.00 |
| Jun 30, 2024 | 804.64 Mn |
| Mar 31, 2024 | 732.64 Mn |
| Dec 31, 2023 | 755.15 Mn |
| Sep 30, 2023 | 743.97 Mn |
| Jun 30, 2023 | 732.64 Mn |
| Mar 31, 2023 | 732.64 Mn |
| Dec 31, 2022 | 587.77 Mn |
| Sep 30, 2022 | 617.92 Mn |
| Jun 30, 2022 | 512.81 Mn |
| Mar 31, 2022 | 508.64 Mn |
| Dec 31, 2021 | 489.50 Mn |
| Sep 30, 2021 | 483.12 Mn |
| Jun 30, 2021 | 478.19 Mn |